The role of the systemic disbalance of serum cytokine levels in pathogenesis of retinopathy of prematurity


如何引用文章

全文:

详细

The present study of the systemic disbalance of the serum cytokine levels included 80 prematurely born children before they developed clinical manifestations of retinopathy of prematurity (ROP). The analysis of the relationship between the characteristics of the cytokine status and the development of ROPduring the subsequent period was undertaken. It was shown that the frequency of detection of cytokines and their concentration in the blood serumof the premature infants are subject to broad variations. The study revealed the tendency toward the prevalence of potentially “pathogenic” (angiogenic, proinflammatory) cytokines in the sera of the premature children who later developed the “threshold” stage of ROPwhich dictated the necessity of laser coagulation of the avascular retinal regions. Of special interest are the observations of serum IGF-II and TGF-beta levels. The former of these parameters showed the fairly well-apparent tendency toward increase in the group of the children with the “threshold” stage of ROP while the letter tended to decrease. It is concluded that the further investigations into the relationship ofserum IGF-II and TGF-beta levelswith those of VEGF at different stages of ROP evolution have good prospects.

作者简介

L. Katargina

The Helmholtz Moscow Research Institute of Eye Diseases

105062, Moscow, Russia

O. Slepova

The Helmholtz Moscow Research Institute of Eye Diseases

105062, Moscow, Russia

E. Demchenko

The Helmholtz Moscow Research Institute of Eye Diseases

105062, Moscow, Russia

Natal'ya Osipova

The Helmholtz Moscow Research Institute of Eye Diseases

Email: natashamma@mail.ru
105062, Moscow, Russia

参考

  1. Phelps D.L. Retinopathy of prematurity. Pediatr. Clin. N. Am. 2004; 40: 705-14.
  2. O’Conner M.T., Vohr B.R., Tucker R., Cashore W. Is retinopathy of prematurity increasing among infants less than 1250 g birth weight? J. Perinatol. 2003; 23: 673-8.
  3. Sood B.G., Madan A., Saha Sh., Schendel D., Thorsen P., Skogstrand K. et al. Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr. Res. 2010; 67 (4): 394-400.
  4. Silveira R.C., Fortes Filho J.B., Procianoy R.S. Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants. Invest. Ophthalmol. Vis. Sci. 2011; 52 (3): 1297-301.
  5. Villegas-Becerril E., González-Fernández R., Perula-Torres L., Gallardo-Galera J.M. IGF-I, VEGF and bFGF as predictive factors for the onset of retinopathy of prematurity (ROP). Arch. Soc. Esp. Oftalmol. 2006; 81 (11): 641-6.
  6. Катаргина Л.А., Слепова О.С., Скрипец П.П., Дементьева Г.М. Гуморальный иммунный ответ на S-антиген сетчатки у недоношенных детей с ретинопатией недоношенных. Вестник офтальмологии. 2003; 1: 20-2.
  7. Smith L.E.H. Pathogenesis of retinopathy of prematurity. Semin. Neonatol. 2003; 8: 469-73.
  8. Федеральные клинические рекомендации «Диагностика, мониторинг и лечение активной фазы ретинопатии недоношенных» (Национальный протокол). Российская педиатрическая офтальмология. 2015; 1: 54-61.
  9. Yalin Imamoglu E., Gunay M., Gursoy T., Imamoglu S., Balci Ekmekci O., Celik G. et al. Effect of laser photocoagulation on plasma levels of VEGF-A, VEGFR-2, and Tie2 in infants with retinopathy of prematurity. J. AAPOS. 2014; 18 (5): 466-70.
  10. Hellstrom A., Engstrom E., Hard A.-L. et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003; 112: 1016-20.
  11. Hellstrom A., Perruzzi C., Ju M. et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. USA. 2001; 98: 5804-8.
  12. Castellon R., Hamdi H.K., Sacerio I., Aoki A.M., Kenney M.C., Ljubimov A.V. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp. Eye. Res. 2002; 74: 523-35.
  13. Wahl S.M. Transforming growth factor-beta: innately bipolar. Curr. Opin. Immunol. 2007; 19: 55-62.
  14. Qiao H., Sonoda K.H., Ikeda Y., Yoshimura T., Hijioka K., Jo Y.J. et al. Interleukin-18 regulates pathological intraocular neovascularization. J. Leukoc. Biol. 2007; 81: 1012-21.
  15. Altinova A.E., Yetkin I., Akbay E., Bukan N., Arslan M. Serum IL-18 levels in patients with type 1 diabetes: relations to metabolic control and microvascular complications. Cytokine. 2008; 42: 217-21.

版权所有 © Eco-Vector, 2015


 


##common.cookie##